Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients

• Mercedes Herrera,
• Alberto Berral-González,
• Igor López-Cade,
• Cristina Galindo-Pumariño,
• Santiago Bueno-Fortes,
• Manuel Martín-Merino,
• Alfredo Carrato,
• Alberto Ocaña,
• Carolina De La Pinta,
• Ana López-Alfonso,
• Cristina Peña,
• Vanesa García-Barberán,
• Javier De Las Rivas

Affiliations

Mercedes Herrera

Department of Oncology-Pathology, Karolinska Institutet

Alberto Berral-González

Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL)

Igor López-Cade

Molecular Oncology Laboratory, Instituto de Investigación Sanitaria San Carlos (IdISSC)

Cristina Galindo-Pumariño

Medical Oncology Department, Ramón y Cajal University Hospital, IRYCIS, CIBERONC, Alcalá University

Santiago Bueno-Fortes

Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL)

Manuel Martín-Merino

Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL)

Alfredo Carrato

Medical Oncology Department, Ramón y Cajal University Hospital, IRYCIS, CIBERONC, Alcalá University

Alberto Ocaña

Experimental Therapeutics Unit, Instituto de Investigación Sanitaria San Carlos (IdISSC) and CIBERONC

Carolina De La Pinta

Radio-Oncology Department, Ramón y Cajal University Hospital, IRYCIS, Alcalá University

Ana López-Alfonso

Medical Oncology Department, Infanta Leonor Hospital

Cristina Peña

Medical Oncology Department, Ramón y Cajal University Hospital, IRYCIS, CIBERONC, Alcalá University

Vanesa García-Barberán

Molecular Oncology Laboratory, Instituto de Investigación Sanitaria San Carlos (IdISSC)

Javier De Las Rivas

Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL)